Aufsatz(elektronisch)#18. November 2010
Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study
In: Journal of the International AIDS Society, Band 13, S. P43-P43
ISSN: 1758-2652